Amneal Pharmaceuticals
Amneal Pharmaceuticals
  • 58
  • 259 398
Get to Know ONGENTYS® (opicapone) capsules
Amneal markets and distributes ONGENTYS® in the U.S.
ONGENTYS® (opicapone) capsules is a prescription medicine used with levodopa and carbidopa in people with Parkinson's disease (PD) who are having "OFF" episodes. Visit www.Ongentys.com for more information.
It is not known if ONGENTYS is safe and effective in children.
IMPORTANT SAFETY INFORMATION
Do not take ONGENTYS if you:
• take a type of medicine called a non-selective monoamine-oxidase (MAO) inhibitor.
• have a tumor that secretes hormones known as catecholamines.
Before taking ONGENTYS, tell your healthcare provider about all of your medical conditions, including if you:
• have daytime sleepiness from a sleep disorder, have unexpected periods of sleep or sleepiness, or take a medicine to help you sleep or that makes you feel sleepy.
• have had intense urges or unusual behaviors, including gambling, increased sex drive, binge eating, or compulsive shopping.
• have a history of uncontrolled sudden movements (dyskinesia).
• have had hallucinations or psychosis.
• have liver or kidney problems.
• are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take nonselective MAO inhibitors (such as phenelzine, tranylcypromine, and isocarboxazid) or catecholamine medicines (such as isoproterenol, epinephrine, norepinephrine, dopamine, and dobutamine), regardless of how you take the medicine (by mouth, inhaled, or by injection).
ONGENTYS and other medicines may affect each other causing side effects. ONGENTYS may affect the way other medicines work, and other medicines may affect how ONGENTYS works.
What should I avoid while taking ONGENTYS?
• Do not drive, operate machinery, or do other dangerous activities until you know how ONGENTYS affects you.
What are the possible side effects of ONGENTYS?
ONGENTYS may cause serious side effects, including:
• Falling asleep during normal activities such as driving a car, talking or eating while taking ONGENTYS or other medicines used to treat Parkinson's disease, without being drowsy or without warning. This may result in having accidents. Your chances of falling asleep while taking ONGENTYS are higher if you take other medicines that cause drowsiness.
• Low blood pressure or dizziness, light headedness, or fainting.
• Uncontrolled sudden movements (dyskinesia). ONGENTYS may cause uncontrolled sudden movements or make such movements worse or happen more often.
• Seeing, hearing, or feeling things that are not real (hallucinations), believing things that are not real (delusions), or aggressive behavior.
• Unusual urges (impulse control and compulsive disorders) such as urges to gamble, increased sexual urges, strong urges to spend money, binge eating, and the inability to control these urges.
Tell your healthcare provider if you experience any of these side effects or notice changes in your behavior.
The most common side effects of ONGENTYS include uncontrolled sudden movements (dyskinesia), constipation, increase in an enzyme called blood creatine kinase, low blood pressure, and weight loss.
These are not all of the possible side effects of ONGENTYS. Call your healthcare provider for medical advice about side effects.
To report SUSPECTED ADVERSE REACTIONS, contact Amneal Specialty, a division of Amneal Pharmaceuticals, LLC at 1-877-835-5472 or the FDA at 1-800-FDA-1088 or fda.gov/medwatch
Please see ONGENTYS full Product Information: www.ongentys.com/assets/pdf/ONGENTYS-full-Prescribing-Information.pdf
Переглядів: 6 543

Відео

Amneal and Metsera Announce Strategic Collaboration
Переглядів 46521 день тому
Today we announced a strategic collaboration with Metsera, a clinical-stage biopharmaceutical company, to accelerate the next-generation medicines for obesity and metabolic diseases. We are excited to leverage our deep expertise in product development, high-quality and cost-effective manufacturing, and our ability to rapidly scale-up to help increase access to this important new category of med...
Next is Now
Переглядів 340Місяць тому
Today, we launched CREXONT® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease. CREXONT® is now broadly available at U.S. pharmacies. investors.amneal.com/news/press-releases/press-release-details/2024/Amneal-Launches-CREXONT-Carbidopa-and-Levodopa-Extended-Release-Capsules-for-Treatment-of-Parkinsons-Disease/default.aspx Amneal has a long history of wor...
Amneal is Rising in Injectables
Переглядів 804Місяць тому
We’ve set high goals for our future in injectables, including becoming Top 5 in the U.S. and a global player. Recently, we’ve significantly expanded our portfolio and pipeline and have tripled our manufacturing capacity. But it’s our people who are truly elevating our leadership position in this complex, highly sophisticated space. Special thanks to (in order of appearance): Vijay Shah, Vice Pr...
Amneal Leaders Discuss CREXONT® Approval
Переглядів 1,2 тис.2 місяці тому
On August 7, 2024, we announced that the U.S. Food and Drug Administration has approved CREXONT® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease in adults. This video spotlights some of our leaders talking about this exciting milestone. See Important Safety Information at the end of this video and at crexont.com/. CREXONT® (carbidopa and levodopa) ext...
#WeAreAmneal - Miran
Переглядів 8734 місяці тому
Miran's story is a powerful reminder of how our supportive leadership and commitment to personal and professional development make Amneal a great place to build a career. #WeAreAmneal
Expertise in Complex & Top-Quality Medicines
Переглядів 166 тис.4 місяці тому
We know that our reputation as a leader in complex and top-quality medicines grows each day with each shipment of our 280 products. Special thanks to (in order of appearance): Manali Patel, Director, Quality Control Lab; Keith Nelson, Senior Manager, Operations Management; and Sachin Patel, Associate Director, Quality Assurance.
Delivering Lifesaving Medicines
Переглядів 7675 місяців тому
By enhancing over-the-counter (OTC) access to Naloxone HCl Nasal Spray, we hope to get this affordable, lifesaving medicine into the hands of more people to help treat opioid overdose. Amneal Naloxone Nasal Spray, 4 mg is now available in the U.S. without a prescription under the Amneal brand, and at select major U.S. pharmacies as the store private label product. Learn more about Amneal’s over...
Building Genuine Relationships in Parkinson's
Переглядів 1705 місяців тому
Building genuine relationships helps power our mission to make healthy possible. As a company committed to the Parkinson’s community, we continue to look for more ways to serve and support people with Parkinson’s disease, their loved ones and care partners, and the physicians who treat them.
Becoming a Leader in Parkinson’s
Переглядів 2 тис.5 місяців тому
Our purpose in Parkinson’s is clear: to be a leader… for providers and patients. Hear from our team and members of the Parkinson’s community on what being a leader in Parkinson’s means to them. Special thanks to (in order of appearance): Kelly Curia-Schmidt, National Sales Director; Joe Renda, SVP, Chief Commercial Officer- Specialty; Dr. Drew Falconer; Bryan Cupito, Senior Region Business Mana...
Premier Specialty Organization
Переглядів 4165 місяців тому
What does building a Premiere Specialty business mean to Amneal? Some of our Specialty Leadership team members share their visions for what we're building together. Special thanks (in order of appearance): Helen Kouhi, Odalys Garcia-Rodriguez, Kelly Curia-Schmidt, David Okimoto, Fernando Arcila, Dr. Stanley Fisher, and Jennifer Altier.
#WeAreAmneal - Gurnish
Переглядів 3866 місяців тому
Gurnish's words echo a sentiment shared by many at Amneal - it is a catalyst for growth where everyone is equipped to surpass their own expectations. Here's to being part of a team committed to making healthy possible. #WeAreAmneal
Spring 2024 Global Town Hall
Переглядів 1,3 тис.6 місяців тому
Our talented team came together last Thursday for our Spring virtual Global Town Hall. Co-Founders and Co-CEOs Chirag and Chintu Patel leveraged the event to recognize team efforts and align all 7,800 colleagues around our exciting plans for the future.
Our Focus on Trust & Transparency
Переглядів 6 тис.7 місяців тому
Trust & transparency are the superpowers of our U.S. Generics commercial team. Special thanks to (in order of appearance): Tony Rosa, Kammi Wilson, Andy Cline, Jeremy Poland, Tony Hodges, AJ Lefave, Gina McFarland, and Dave Hardin.
International Women’s Day 2024
Переглядів 1,6 тис.7 місяців тому
On this #InternationalWomensDay, we celebrate the many women who drive our company forward. #AmnealWomen #IWD2024
Amneal India Launches Oncology Portfolio at National Sales Meeting
Переглядів 1,1 тис.8 місяців тому
Amneal India Launches Oncology Portfolio at National Sales Meeting
Voices of Leadership: Srinivas Kone, PhD
Переглядів 6308 місяців тому
Voices of Leadership: Srinivas Kone, PhD
Voices of Leadership: Nikita Shah
Переглядів 7369 місяців тому
Voices of Leadership: Nikita Shah
Voices of Leadership: Tasos Konidaris
Переглядів 3899 місяців тому
Voices of Leadership: Tasos Konidaris
Acknowledging Teamwork & Growth
Переглядів 2,8 тис.9 місяців тому
Acknowledging Teamwork & Growth
Our Story, Our People
Переглядів 1,9 тис.10 місяців тому
Our Story, Our People
Investing in New Technologies
Переглядів 9 тис.Рік тому
Investing in New Technologies
Amneal’s Parkinson’s Team Learns from Patients
Переглядів 384Рік тому
Amneal’s Parkinson’s Team Learns from Patients
Rahul Maitra Describes Amneal’s Purpose: Making Healthy Possible
Переглядів 1,6 тис.Рік тому
Rahul Maitra Describes Amneal’s Purpose: Making Healthy Possible
Amneal’s Focus on Quality with Sanjay Kumar Jain, PhD
Переглядів 2 тис.Рік тому
Amneal’s Focus on Quality with Sanjay Kumar Jain, PhD
Growing Amneal India & Career Opportunities
Переглядів 1,3 тис.Рік тому
Growing Amneal India & Career Opportunities
Voices of Leadership: Harsher Singh
Переглядів 589Рік тому
Voices of Leadership: Harsher Singh
Voices of Leadership: Joe Renda
Переглядів 659Рік тому
Voices of Leadership: Joe Renda
Amneal's Parkinson’s Team Learns from Healthcare Providers
Переглядів 333Рік тому
Amneal's Parkinson’s Team Learns from Healthcare Providers
Voices of Leadership: Shyamakant Giri
Переглядів 1,2 тис.Рік тому
Voices of Leadership: Shyamakant Giri